WST West Pharmaceutical Services, Inc.
Healthcare
Price
$349.69
Intrinsic value
$67.73
Buy price
$54.19
Discount
-416.3%
DCF walkthrough
Near-term growth (g1)1.40%
Terminal growth (g2)3.50%
Years of g1 growth4
Discount rate9.00%
Margin of safety20.00%
- Operating CF
- $662,200,000.00
- Total debt
- $316,500,000.00
- Cash & STI
- $435,800,000.00
- Shares out.
- 71,300,000
Overvalued
Intrinsic value$67.74
Buy price (with MOS)$54.19
Current price$349.69
Discount to intrinsic value-416.2%
7-step quality scorecard
ROE quality
HIGH_CONSISTENT- Average ROE
- 19.1%
- Current ROE
- 15.5%
- Minimum ROE
- 15.5%
Debt quality
CONSERVATIVE- Debt / Equity
- 0.10x
Moat proxy
MODERATE_PROXYCash-flow reliability
OK- Operating CF / Net income
- 1.17x
Technical chart
Confluence: WEAK (1/3)Weekly candles, ~3 years. Yellow line: 10-week EMA. Dashed lines: Fibonacci retracement of the last 52-week swing. Green arrow: an active DR1 support reclaim.
Assumptions & data quality
- Data source
- yfinance
- Growth (g1) source
- min(cfCAGR,revenueCAGR)
- Valuation model
- DCF_OCF
- Debt as % of DCF PV
- 6.7%
- Public economic interest
- 100.0%
These are model outputs built on assumptions (growth rate, discount rate, margin of safety), not facts - trust but verify, especially for LOW cash-flow-reliability or UNKNOWN-quality rows.